Molecular Docking studies of Phytocompounds of Rheum emodi Wall with proteins responsible for antibiotic resistance in bacterial and fungal pathogens: In silico approach to enhance the bio-availability of antibiotics
Rajan RoltaiD, Deeksha Salaria, Vikas KumariD, Chirag N. PateliD, Anuradha SourirajaniD, David J. BaumleriD, Kamal DeviD
Abstract
Rheum emodi Wall. (Himalayan rhubarb) has been used to cure many human diseases. Literature survey demonstrated that it has many pharmacological activities such as antioxidant, antimicrobial, antiviral, anticancer and wound healing. The present study was aimed to understand if major phytocompounds of Rheum emodi could bind proteins responsible for antibiotic resistance in bacterial and fungal pathogens and enhance the potency of antibiotics. The major phytocompounds of R. emodi (emodin, rhein-13c6 and chrysophenodimethy ether) were retrieved from Pubchem and target proteins were retrieved from RCSB protein data bank. The docking study was performed with Hex 8.0.0 software and molinspiration, swiss ADME servers were used for determination of Lipinski rule of 5, drug-likeness prediction respectively, whereas, admetSAR and Protox-II tools were used for toxicity prediction. Among all the selected phytocompounds, emodin showed the best binding energy of -235.82 Kcal mol-1 and -245 Kcal mol-1 with cytochrome P450 14 alpha-sterol demethylase (PDB ID: 1EA1) and N-myristoyl transferase (PDB ID: 1IYL) receptors, respectively, which is more than that of fluconazole (-224.12 kcalmol-1 and -161.14 kcal mol-1). Similarly, with Penicillin binding protein 3 (PDB ID: 3VSL) receptor, emodin and Chrysophanol dimethyl ether showed highest binding energy of - 216.68 Kcal mol-1 and -215.58 kcal mol-1 which is comparable to erythromycin (-263.63 kcal mol-1), chloramphanicol (-217.34 kcal mol-1) and tetracycline (-263.63 kcal mol-1). All the selected phytocompounds also fulfill Lipinski rule, non-carcinogenic and non-cytotoxic in nature. These compounds also showed high LD50 value showing non-toxicity of these phytocompounds. Graphical abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=99 SRC="FIGDIR/small/086835v1_ufig1.gif" ALT="Figure 1"> View larger version (34K): org.highwire.dtl.DTLVardef@384d63org.highwire.dtl.DTLVardef@60d824org.highwire.dtl.DTLVardef@e23adorg.highwire.dtl.DTLVardef@485efe_HPS_FORMAT_FIGEXP M_FIG C_FIG
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 41
- FWCI
- 2.48
- Field percentile
- top 9%
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Screening of anti-Acinetobacter baumannii phytochemicals, based on the potential inhibitory effect on OmpA and OmpW functions
Shahab Shahryari, Parvin Mohammadnejad, Kambiz Akbari Noghabi·Royal Society Open SciencePeer-reviewed·Aug 1, 2021
- Integrated Artificial Intelligence and Quantum Chemistry Approach for the Rational Design of Novel Antibacterial Agents against Ralstonia solanacearum.
Dipti Aniket Gulumbe, Goldie Tiwari, … Satyabharati Giri·bioRxiv·Mar 17, 2026
- In silico and In vitro evaluation of the anti-inflammatory and antioxidant potential of Cymbopogon citratus from North-western Himalayas
V. Kumar, D. Salaria, … A. Sourirajan·bioRxiv·May 31, 2020
- Investigation of the anti-TB potential of selected alkaloid constituents using molecular docking approach
Mohammad Kawsar Sharif Siam, Mohammad Umer Sharif Shohan, Zaira Zafroon·bioRxiv·Apr 28, 2020
- High-Throughput Screening Reveals Potential Inhibitors Targeting Trimethoprim-Resistant DfrA1 Protein in Klebsiella pneumoniae and Escherichia coli
Soharth Hasnat, Soaibur Rahman, … Tofazzal Islam·bioRxiv·Nov 18, 2024
- Molecular docking, validation, dynamic simulation and pharmacokinetic prediction of natural compounds against Mycobacterium tuberculosis Beta-lactamase BlaC
Sandra Sreekumar, J.L Bhagya Jyothi, … Immanuel Dhanasingh·bioRxiv·Jan 7, 2025